1. Clinical Significance of miR-149 in the Survival of Patients with Laryngeal Squamous Cell Carcinoma.
- Author
-
Xu, Yi, Lin, Yun-Peng, Yang, Dong, Zhang, Geng, and Zhou, Hui-Fang
- Subjects
SQUAMOUS cell carcinoma ,RNA analysis ,LARYNGEAL tumors ,APOPTOSIS ,CELL culture ,CELL lines ,CELL physiology ,FLOW cytometry ,GENETIC techniques ,POLYMERASE chain reaction ,PROBABILITY theory ,RNA ,T-test (Statistics) ,PROPORTIONAL hazards models ,REVERSE transcriptase polymerase chain reaction ,DATA analysis software ,DESCRIPTIVE statistics ,KAPLAN-Meier estimator ,IN vitro studies ,LOG-rank test ,MANN Whitney U Test ,PROGNOSIS - Abstract
MicroRNAs (miRNAs) play critical roles in the progression of laryngeal cancer (LC). In this study, we aimed to investigate whether miR-149 is associated with the prognosis of patients with LC. A total of 97 laryngeal squamous cell carcinoma patients who underwent tumor resection were included in our follow-up study. In vitro studies was performed in cancer cell line Hep-2 to explore the antitumor role of miR-149 in LC. We found that the expression of miR-149 was significantly lower in tumor tissues, compared with vocal cord polyp tissues (P<0.05). Kaplan-Meier analysis revealed that miR-149 expression status is significantly associated with survival duration (log rank test, P<0.05), and multivariate Cox regression analysis revealed that patients with low miR-149 expression had shorter survival times compared with patients with high miR-149 expression. In vitro studies revealed that the exogenous expression of miRNA-149 inhibits the proliferation of human Hep-2 cells and induces cell apoptosis. Our study suggests that miR-149 expression in laryngeal squamous cell carcinoma tissues is critically associated with the prognosis of patients, and the ectopic expression of miR-149 in Hep-2 cells inhibits proliferation and cell cycle progression. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF